PCG
AMED

Private Capital Group’s Amedisys AMED Stock Holding History

Private Capital Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$12K Sell
110
-9
-8% -$1.15K 0.01% 978
2022
Q1 		$21K Buy
119
+48
+68% +$7.17K ﹤0.01% 1006
2021
Q4 		$12K Hold
71
– – ﹤0.01% 1232
2021
Q3 		$11K Sell
71
-15
-17% -$3.12K ﹤0.01% 1291
2021
Q2 		$21K Hold
86
– – ﹤0.01% 1060
2021
Q1 		$23K Buy
86
+40
+87% +$11.3K 0.01% 991
2020
Q4 		$14K Sell
46
-56
-55% -$14.4K ﹤0.01% 1305
2020
Q3 		$24K Sell
102
-1
-1% -$227 0.01% 1015
2020
Q2 		$20K Sell
103
-24
-19% -$4.48K ﹤0.01% 1096
2020
Q1 		$23K Buy
127
+91
+253% +$16.2K 0.01% 954
2019
Q4 		$6K Hold
36
– – ﹤0.01% 1445
2019
Q3 		$5K Buy
36
+30
+500% +$3.9K ﹤0.01% 1653
2019
Q2 		$1K Sell
6
-30
-83% -$3.56K ﹤0.01% 1993
2019
Q1 		$4K Sell
36
-21
-37% -$2.64K ﹤0.01% 1718
2018
Q4 		$7K Buy
+57
New +$6.72K ﹤0.01% 1507
2018
Q3 		– Sell
-6
Closed – – 2180
2018
Q2 		$0 Sell
6
-103
-94% -$7.56K ﹤0.01% 2123
2018
Q1 		$7K Buy
109
+6
+6% +$342 ﹤0.01% 1490
2017
Q4 		$5K Buy
+103
New +$5.43K ﹤0.01% 1618

Other funds holding AMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Private Capital Group's AMED Position: Q2 2022 in Review

Private Capital Group reduced its Amedisys (AMED) stake by 7.6% in Q2 2022, selling an estimated $1.15K and leaving 110 shares worth $12K. The position accounts for 0.01% of the portfolio, ranked #978.

Private Capital Group first reported a position in AMED in Q4 2017 and has held it in 18 quarters since. The position peaked at $24K in Q3 2020. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2022.

  • Private Capital Group held 110 shares of Amedisys worth $12K as of Q2 2022.
  • Private Capital Group sold 9 Amedisys shares in Q2 2022, an estimated $1.15K.
  • Amedisys made up 0.01% of Private Capital Group's portfolio in Q2 2022, its #978 holding.
  • Private Capital Group first reported a position in Amedisys in Q4 2017 and has held it in 18 quarters since.
  • Private Capital Group's Amedisys position peaked at $24K in Q3 2020.
  • 288 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.